CD34 and chronic myelogenous leukemia, BCR-ABL1 positive: Administration of metformin clearly reduced engraftment of CML stem/progenitor cells as indicated by decreased numbers of CD45+CD34+ cells in the bone marrow of CML PDX models at 8 weeks post transplantation (Fig. 5B).